dm+d Governance
dm+d Programme Board
The dm+d Programme Board is chaired by the Head of Medicines, Pharmacy and Industry Group, Department of Health. The Programme Board is accountable to the NHS CFH Programme Delivery Team (PDT). The Programme Board has ultimate responsibility for all aspects of dm+d. The dm+d Programme Board is supported by and assigns some responsibilities to the dm+d Editorial Group and dm+d Implementation Group.
dm+d Editorial Group
The Editorial Group is accountable to the dm+d Programme Board and is responsible for:
- Defining and maintaining the editorial policy to ensure the safe and usable delivery of the clinical content.
- Ensuring the dm+d is maintained in accordance with its policy.
- Approving major content changes such as those necessary to support new use-cases.
Editorial policy is determined by the Editorial Group Latest Editorial Policy available for download.
dm+d Implementation Group
The Implementation Group is accountable to the dm+d Programme Board. It is responsible for:
- Non-content changes in dm+d that impact on the suppliers' ability to implement dm+d in systems.
- Changes that impact on the dm+d Team's capacity to deliver the products and services.
- Overseeing structural changes and extensions or adjuncts to dm+d.
- Overseeing the technical changes that may be required to meet authoring and user requirements.
- Ensuring that the appropriate guidance is available to users for each dm+d use-case that has been authorised by the Programme Board.
dm+d Stakeholder Groups
The dm+d Programme Board recognises that dm+d Stakeholders are key in moving dm+d forward and prioritising issues for resolution. Two separate forums have been created which will align the governance framework of dm+d with that of other NHS CFH Programmes, namely a User Group and a Supplier Group.
Whilst stakeholder feedback is received via a number of sources such as the dm+d helpdesk, the Stakeholder Groups are the main forum for identifying and prioritising issues as well as providing feedback on proposals from the Implementation and Editorial Groups. The Stakeholders are consulted as, and when, input is required, for example when structural or significant content changes are proposed.
The User group represents end-users of, and data contributors to, the dm+d. The Supplier group represents system suppliers and developers that are designing and implementing clinical systems. The relationship between the Stakeholder, Editorial and Implementation groups and the Programme Board is shown in the diagram below.
Regular updates on the activities and progress of the dm+d Programme Board, Editorial Group and Implementation Group will be available from this website.